Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-16

FDA Approved: BICALUTAMIDE — Supplemental Application (Viona Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for bicalutamide filed by Viona Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bicalutamide (bicalutamide)

Snippet

SUPPL AP for BICALUTAMIDE (BICALUTAMIDE)